发明授权
- 专利标题: MDR reversal agents
- 专利标题(中): MDR逆转剂
-
申请号: US92653申请日: 1993-07-16
-
公开(公告)号: US5387685A公开(公告)日: 1995-02-07
- 发明人: Dennis Powell , Rolf Paul , William A. Hallett , Dan M. Berger , Minu D. Dutia
- 申请人: Dennis Powell , Rolf Paul , William A. Hallett , Dan M. Berger , Minu D. Dutia
- 专利权人: American Cyanamid Co
- 当前专利权人: American Cyanamid Co
- 主分类号: A61K31/40
- IPC分类号: A61K31/40 ; A61K31/403 ; A61K31/4035 ; A61K31/47 ; A61K31/472 ; A61K45/00 ; A61P35/00 ; A61P43/00 ; C07C323/07 ; C07C323/16 ; C07C323/56 ; C07C323/60 ; C07D209/44 ; C07D209/48 ; C07D215/20 ; C07D217/02 ; C07D217/04 ; C07D217/06 ; C07D217/20 ; C07D217/24 ; C07D401/12 ; C07D405/06 ; C07D491/04 ; C07D491/056 ; C07D521/00 ; C07F7/10 ; C07F7/18 ; C07D217/12
摘要:
Compounds of the general formula: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are herein described, A is a straight or branched (C.sub.2 -C.sub.12)alkyl or a phenyl moiety and B is a moiety of the formula: ##STR2## The compounds are effective in potentiating the activity of chemotherapeutic anti-cancer agents by increasing the sensitivity of multi-drug resistant cells to such chemotherapeutic agents.
公开/授权文献
- USD422711S Moxa stand 公开/授权日:2000-04-11
信息查询